Interleukin‐17 increases the expression of Toll‐like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast‐like synoviocytes
Open Access
- 30 October 2013
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 141 (3) , 353-361
Abstract
Summary: We examined the effect of interleukin‐17 (IL‐17) on the expression of Toll‐like receptors (TLRs) in fibroblast‐like synoviocytes (FLS) from patients with rheumatoid arthritis (RA) and osteoarthritis (OA). We investigated the region downstream of IL‐17 for TLR expression. We also investigated the downstream signals responsible for the effect of IL‐17 in TLR expression. Levels of IL‐17 protein in the serum and synovial fluid of RA and OA patients were measured by ELISA. The IL‐17 mRNA expression in peripheral blood mononuclear cells and synovial fluid mononuclear cells was measured by RT‐PCR. RA and OA FLS were incubated with IL‐17 and/or IL‐23 for 24 hr. To block the signal transducer and activator of transcription 3 (STAT3) pathway, FLS were treated with S3I‐201 before incubation with IL‐17 and IL‐23. Synovial tissue samples from RA and OA patients were stained with antibodies to IL‐17, TLR2, TLR3, TLR4, STAT3 and phospho‐STAT3. Levels of IL‐17 protein were higher in the serum and synovial fluid from RA patients compared with those from OA patients. The IL‐17 mRNA expression in synovial fluid monocytes was also higher in RA than in OA patients. Immunohistochemical staining showed greater expression of IL‐17, TLR2, TLR3 and TLR4 in synovial samples from RA compared with OA patients. Interleukin‐17 increased the expression of TLR2, TLR3 and TLR4 in RA FLS; IL‐23 augmented the IL‐17‐induced expression of TLR2, TLR3 and TLR4 in RA FLS. Blocking STAT3 with S3I‐201 reduced IL‐17‐induced TLR3 expression in RA FLS. Our results suggest that IL‐17 is a major cytokine in pathogenesis on RA. The IL‐17 influences the innate immune system by increasing the synovial expression of TLR2, TLR3 and TLR4. We may control TLR3 expression via the STAT3 pathway in RA FLS.Keywords
Funding Information
- the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2009-0081791)
This publication has 22 references indexed in Scilit:
- IL‐23 in the Pathogenesis of Rheumatoid ArthritisScandinavian Journal of Immunology, 2010
- Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activationJournal of Leukocyte Biology, 2007
- Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activityProceedings of the National Academy of Sciences, 2007
- Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activationImmunology Letters, 2007
- The clinical role of IL‐23p19 in patients with rheumatoid arthritisScandinavian Journal of Rheumatology, 2007
- Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF- B- and p38 MAPK-dependent signalling pathwaysRheumatology, 2006
- STAT3 and NF-κB Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient MiceThe Journal of Immunology, 2006
- Toll-like receptor 2 controls expansion and function of regulatory T cellsJournal of Clinical Investigation, 2006
- Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteriaProceedings of the National Academy of Sciences, 2004
- Synovial activation in rheumatoid arthritisFrontiers in Bioscience-Landmark, 2004